{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T14:47:47Z","timestamp":1783003667871,"version":"3.54.5"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T00:00:00Z","timestamp":1713398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T00:00:00Z","timestamp":1713398400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"First affiliated hospital of Harbin Medical University","award":["2016B004"],"award-info":[{"award-number":["2016B004"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neurol Belg"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s13760-024-02537-6","type":"journal-article","created":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T04:01:31Z","timestamp":1713412891000},"page":"1569-1580","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Clinical features, cerebrospinal fluid changes, and prognosis in Chinese patients with autoimmune encephalitis"],"prefix":"10.1007","volume":"124","author":[{"given":"Wu","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Mengke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su","family":"Zhiqiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gu","family":"Jiaao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4693-8208","authenticated-orcid":false,"given":"Guan","family":"Fulin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,18]]},"reference":[{"key":"2537_CR1","doi-asserted-by":"publisher","first-page":"804","DOI":"10.3389\/fneur.2019.00804","volume":"10","author":"T Blinder","year":"2019","unstructured":"Blinder T, Lewerenz J (2019) Cerebrospinal fluid findings in patients with autoimmune encephalitis\u2014a systematic analysis. Front Neurol 10:804","journal-title":"Front Neurol"},{"issue":"6","key":"2537_CR2","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/j.hoc.2006.09.011","volume":"20","author":"J Dalmau","year":"2006","unstructured":"Dalmau J, Bataller L (2006) Clinical and immunological diversity of limbic encephalitis: a model for paraneoplastic neurologic disorders. Hematol Oncol Clin N Am 20(6):1319\u20131335","journal-title":"Hematol Oncol Clin N Am"},{"issue":"6","key":"2537_CR3","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000181","volume":"2","author":"J Dalmau","year":"2015","unstructured":"Dalmau J (2015) Autoimmunity: the good, the bad, and the ugly. Neurol Neuroimmunol Neuroinflamm 2(6):e181","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"4","key":"2537_CR4","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1055\/s-0034-1390394","volume":"34","author":"JJ Linnoila","year":"2014","unstructured":"Linnoila JJ, Rosenfeld MR, Dalmau J (2014) Neuronal surface antibody-mediated autoimmune encephalitis. Semin Neurol 34(4):458\u2013466","journal-title":"Semin Neurol"},{"key":"2537_CR5","doi-asserted-by":"publisher","first-page":"31","DOI":"10.17925\/ENR.2013.08.01.31","volume":"8","author":"F Leypoldt","year":"2013","unstructured":"Leypoldt F, Wandinger KP, Bien CG, Dalmau J (2013) Autoimmune encephalitis. Eur Neurol Rev 8:31\u201337","journal-title":"Eur Neurol Rev"},{"issue":"1","key":"2537_CR6","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1590\/0004-282x20170176","volume":"76","author":"LA Dutra","year":"2018","unstructured":"Dutra LA, Abrantes F, Toso FF, Pedroso JL, Barsottini OGP, Hoftberger R (2018) Autoimmune encephalitis: a review of diagnosis and treatment. Arq Neuropsiquiatr 76(1):41\u201349","journal-title":"Arq Neuropsiquiatr"},{"issue":"9","key":"2537_CR7","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1056\/NEJMra1708712","volume":"378","author":"J Dalmau","year":"2018","unstructured":"Dalmau J, Graus F (2018) Antibody-mediated encephalitis. N Engl J Med 378(9):840\u2013851","journal-title":"N Engl J Med"},{"key":"2537_CR8","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S1474-4422(10)70253-2","volume":"10","author":"J Dalmau","year":"2011","unstructured":"Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR, BaliceGordon R (2011) Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol 10:63\u201374","journal-title":"Lancet Neurol"},{"key":"2537_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.652820","volume":"12","author":"TY Zhang","year":"2021","unstructured":"Zhang TY, Cai MT, Zheng Y, Lai QL, Shen CH, Qiao S, Zhang YX (2021) Anti-alpha-amino-3-hydroxy-5- methyl-4- isoxazolepropionic acid receptor encephalitis: a review. Front Immunol 12:652820","journal-title":"Front Immunol"},{"issue":"4","key":"2537_CR10","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/s13760-020-01336-z","volume":"121","author":"Y Li","year":"2021","unstructured":"Li Y, Song F, Liu W, Wang Y (2021) Clinical features of nine cases of leucine-rich glioma inactivated 1 protein antibody-associated encephalitis. Acta Neurol Belg 121(4):889\u2013897","journal-title":"Acta Neurol Belg"},{"issue":"4","key":"2537_CR11","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1164\/rccm.201603-0507OC","volume":"195","author":"E De Montmollin","year":"2017","unstructured":"De Montmollin E, Demeret S, Brule N, Conrad M, Dailler F, Lerolle N, Navellou JC, Schwebel C, Alves M, Cour M, Engrand N, Tonnelier JM, Maury E, Ruckly S, Picard G, Rogemond V, Magalhaes E, Sharshar T, Timsit JF, Honnorat J, Sonneville R, ENCEPHALITICA Study Group (2017) Anti-N-methyl-d-aspartate receptor encephalitis in adult patients requiring intensive care. Am J Respir Crit Care Med 195(4):491\u2013499","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"2537_CR12","doi-asserted-by":"publisher","first-page":"e244","DOI":"10.1212\/WNL.0000000000006783","volume":"92","author":"R Balu","year":"2019","unstructured":"Balu R, Mccracken L, Lancaster E, Graus F, Dalmau J, Titulaer MJ (2019) A score that predicts 1-year functional status in patients with anti-NMDA receptor encephalitis. Neurology 92(3):e244\u2013e252","journal-title":"Neurology"},{"key":"2537_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.646940","volume":"12","author":"T Zrzavy","year":"2021","unstructured":"Zrzavy T, H\u00f6ftberger R, Wimmer I, Berger T, Rommer P, Macher S (2021) Longitudinal CSF findings in autoimmune encephalitis\u2014a monocentric cohort study. Front Immunol 12:646940","journal-title":"Front Immunol"},{"key":"2537_CR14","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.seizure.2017.05.017","volume":"50","author":"S Aurangzeb","year":"2017","unstructured":"Aurangzeb S, Symmonds M, Knight RK, Kennett R, Wehner T, Irani SR (2017) LGI1-antibody encephalitis is characterised by frequent, multifocal clinical and subclinical seizures. Seizure 50:14\u201317","journal-title":"Seizure"},{"key":"2537_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.611597","volume":"12","author":"Z Hayden","year":"2021","unstructured":"Hayden Z, B\u00f3n\u00e9 B, Orsi G, Szots M, Nagy F, Cs\u00e9p\u00e1ny T, Mezei Z, Rajda C, Simon D, Najbauer J, Illes Z, Berki T (2021) Clinical characteristics and outcome of neuronal surface antibody-mediated autoimmune encephalitis patients in a national cohort. Front Neurol 12:611597","journal-title":"Front Neurol"},{"key":"2537_CR16","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jneuroim.2017.08.010","volume":"312","author":"AK Yeshokumar","year":"2017","unstructured":"Yeshokumar AK, Gordon-Lipkin E, Arenivas A (2017) Neurobehavioral outcomes in autoimmune encephalitis. J Neuroimmunol 312:8\u201314","journal-title":"J Neuroimmunol"},{"issue":"12","key":"2537_CR17","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S1474-4422(08)70224-2","volume":"7","author":"J Dalmau","year":"2008","unstructured":"Dalmau J, Gleichman AJ, Hughes EG, Rossi JE, Peng X, Lai M, Dessain SK, Rosenfeld MR, Balice-Gordon R, Lynch DR (2008) Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 7(12):1091\u20131098","journal-title":"Lancet Neurol"},{"issue":"2","key":"2537_CR18","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","volume":"12","author":"MJ Titulaer","year":"2013","unstructured":"Titulaer MJ, McCracken L, Gabilondo I, Armangu\u00e9 T, Glaser C, Iizuka T, Honig LS, Benseler SM, Kawachi I, Martinez-Hernandez E, Aguilar E, Gresa-Arribas N, Ryan-Florance N, Torrents A, Saiz A, Rosenfeld MR, Balice-Gordon R, Graus F, Dalmau J (2013) Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol 12(2):157\u2013165","journal-title":"Lancet Neurol"},{"issue":"Pt 6","key":"2537_CR19","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1093\/brain\/awq113","volume":"133","author":"SR Irani","year":"2010","unstructured":"Irani SR, Bera K, Waters P, Zuliani L, Maxwell S, Zandi MS, Friese MA, Galea I, Kullmann DM, Beeson D, Lang B, Bien CG, Vincent A (2010) N-methyl-d-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain 133(Pt 6):1655\u20131667","journal-title":"Brain"},{"issue":"4","key":"2537_CR20","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.3892\/etm.2015.2689","volume":"10","author":"K Suhs","year":"2015","unstructured":"Suhs K, Wegner F, Skripuletz T, Trebst C, Tayeb SB, Raab P, Stangel M (2015) Heterogeneity of clinical features and corresponding antibodies in seven patients with anti-NMDA receptor encephalitis. Exp Ther Med 10(4):1283\u20131292","journal-title":"Exp Ther Med"},{"issue":"5","key":"2537_CR21","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1007\/s11011-019-00452-x","volume":"34","author":"V Fominykh","year":"2019","unstructured":"Fominykh V, Brylev L, Gaskin V, Luzin R, Yakovlev A, Komoltsev I, Belousova I, Rosliakova A, Guekht A, Gulyaeva N (2019) Neuronal damage and neuroinflammation markers in patients with autoimmune encephalitis and multiple sclerosis. Metab Brain Dis 34(5):1473\u20131485","journal-title":"Metab Brain Dis"},{"issue":"3","key":"2537_CR22","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1002\/ana.24117","volume":"75","author":"MJ Titulaer","year":"2014","unstructured":"Titulaer MJ, H\u00f6ftberger R, Iizuka T, Leypoldt F, McCracken L, Cellucci T, Benson LA, Shu H, Irioka T, Hirano M, Singh G, Cobo Calvo A, Kaida K, Morales PS, Wirtz PW, Yamamoto T, Reindl M, Rosenfeld MR, Graus F, Saiz A, Dalmau J (2014) Overlapping demyelinating syndromes and anti-N-methyl-d-aspartate receptor encephalitis. Ann Neurol 75(3):411\u2013428","journal-title":"Ann Neurol"},{"issue":"6","key":"2537_CR23","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1136\/archdischild-2014-306795","volume":"100","author":"S Wright","year":"2015","unstructured":"Wright S, Hacohen Y, Jacobson L, Agrawal S, Gupta R, Philip S, Smith M, Lim M, Wassmer E (2015) N-Methyl-d-aspartate receptor antibody-mediated neurological disease: results of a UK-based surveillance study in children. Arch Dis Child 100(6):521\u2013526","journal-title":"Arch Dis Child"},{"issue":"2","key":"2537_CR24","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1097\/CCM.0b013e3181cb0968","volume":"38","author":"G Davies","year":"2010","unstructured":"Davies G, Irani SR, Coltart C, Ingle G, Amin Y, Taylor C, Radcliffe J, Hirsch NP, Howard RS, Vincent A, Kullmann DM (2010) Anti-N-methyl-d-aspartate receptor antibodies: a potentially treatable cause of encephalitis in the intensive care unit. Crit Care Med 38(2):679\u2013682","journal-title":"Crit Care Med"},{"issue":"9","key":"2537_CR25","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.4103\/0366-6999.180514","volume":"129","author":"HZ Guan","year":"2016","unstructured":"Guan HZ, Ren HT, Cui LY (2016) Autoimmune encephalitis: an expanding frontier of neuroimmunology. Chin Med J (Engl) 129(9):1122\u20131127","journal-title":"Chin Med J (Engl)"},{"key":"2537_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cca.2013.02.010","volume":"421","author":"BB Suh-Lailam","year":"2013","unstructured":"Suh-Lailam BB, Haven TR, Copple SS, Knapp D, Jaskowski TD, Tebo AE (2013) Anti-NMDA-receptor antibody encephalitis: performance evaluation and laboratory experience with the anti-NMDA-receptor IgG assay. Clin Chim Acta 421:1\u20136","journal-title":"Clin Chim Acta"},{"issue":"3","key":"2537_CR27","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1002\/ana.23917","volume":"75","author":"T Armangue","year":"2014","unstructured":"Armangue T, Titulaer MJ, Sabater L, Pardo-Moreno J, Gresa-Arribas N, Barbero-Bordallo N, Kelley GR, Kyung-Ha N, Takeda A, Nagao T, Takahashi Y, Lizcano A, Carr AS, Graus F, Dalmau J (2014) A novel treatment-responsive encephalitis with frequent opsoclonus and teratoma. Ann Neurol 75(3):435\u2013441","journal-title":"Ann Neurol"},{"key":"2537_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2020.102604","volume":"47","author":"Y Yu","year":"2021","unstructured":"Yu Y, Wu Y, Cao X, Li J, Liao X, Wei J, Huang W (2021) The clinical features and prognosis of anti-NMDAR encephalitis depends on blood brain barrier integrity. Mult Scler Relat Disord 47:102604","journal-title":"Mult Scler Relat Disord"},{"key":"2537_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.621599","volume":"12","author":"W Shan","year":"2021","unstructured":"Shan W, Yang H, Wang Q (2021) Neuronal surface antibody-medicated autoimmune encephalitis (limbic encephalitis) in China: a multiple-center. Retrospective Study. Front Immunol 12:621599","journal-title":"Retrospective Study. Front Immunol"},{"issue":"6","key":"2537_CR30","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1111\/ane.13503","volume":"144","author":"W Chen","year":"2021","unstructured":"Chen W, Wang M, Gao L, Huang Z, Lin Y, Xue Q, Liu G, Zhang Y, Su Y (2021) Neurofunctional outcomes in patients with anti-leucine-rich glioma inactivated 1 encephalitis. Acta Neurol Scand 144(6):632\u2013639","journal-title":"Acta Neurol Scand"},{"key":"2537_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.652864","volume":"12","author":"X Qin","year":"2021","unstructured":"Qin X, Yang H, Zhu F, Wang Q, Shan W (2021) Clinical character of CASPR2 autoimmune encephalitis: a multiple center retrospective study. Front Immunol 12:652864","journal-title":"Front Immunol"},{"issue":"1","key":"2537_CR32","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1186\/s12883-021-02520-1","volume":"21","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Fan S, Ren H, Zhou L, Guan H (2021) Clinical characteristics and prognosis of anti-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor encephalitis. BMC Neurol 21(1):490","journal-title":"BMC Neurol"},{"issue":"1","key":"2537_CR33","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12883-018-1099-z","volume":"18","author":"W Li","year":"2018","unstructured":"Li W, Wu S, Meng Q, Wang Y (2018) Clinical characteristics and short-term prognosis of LGI1 antibody encephalitis: a retrospective case study. BMC Neurol 18(1):96","journal-title":"BMC Neurol"},{"key":"2537_CR34","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.2147\/NDT.S136723","volume":"13","author":"M Wang","year":"2017","unstructured":"Wang M, Cao X, Liu Q, Ma W, Guo X, Liu X (2017) Clinical features of limbic encephalitis with LGI1 antibody. Neuropsychiatr Dis Treat 13:1589\u20131596","journal-title":"Neuropsychiatr Dis Treat"},{"key":"2537_CR35","doi-asserted-by":"publisher","first-page":"539","DOI":"10.3389\/fneur.2019.00539","volume":"10","author":"S Deng","year":"2019","unstructured":"Deng S, Qiu K, Liu H, Wu X, Lei Q, Lu W (2019) Clinical characteristics and short-term prognosis of autoimmune encephalitis: a single-center cohort study in Changsha, China. Front Neurol 10:539","journal-title":"Front Neurol"},{"key":"2537_CR36","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.jocn.2018.11.033","volume":"62","author":"S Aungsumart","year":"2019","unstructured":"Aungsumart S, Ha A, Apiwattanakul M (2019) Abnormal level of consciousness predicts outcomes of patients with anti-NMDA encephalitis. J Clin Neurosci 62:184\u2013187","journal-title":"J Clin Neurosci"},{"issue":"6","key":"2537_CR37","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000001086","volume":"8","author":"M D\u00fcrr","year":"2021","unstructured":"D\u00fcrr M, Nissen G, S\u00fchs KW, Schwenkenbecher P, Geis C, Ringelstein M, Hartung HP, Friese MA, Kaufmann M, Malter MP, Madlener M, Thaler FS, K\u00fcmpfel T, Senel M, H\u00e4usler MG, Schneider H, Bergh FT, Kellinghaus C, Zettl UK, Wandinger KP, Melzer N, Gross CC, Lange P, Dreyhaupt J, Tumani H, Leypoldt F, Lewerenz J (2021) German network for research on autoimmune encephalitis. CSF findings in acute NMDAR and LGI1 antibody-associated autoimmune encephalitis. Neurol Neuroimmunol Neuroinflamm 8(6):e1086","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"9","key":"2537_CR38","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1097\/CCM.0000000000002577","volume":"45","author":"A Seshadri","year":"2017","unstructured":"Seshadri A, Brat GA, Yorkgitis BK, Keegan J, Dolan J, Salim A, Askari R, Lederer JA (2017) Phenotyping the immune response to trauma: a multiparametric systems immunology approach. Crit Care Med 45(9):1523\u20131530","journal-title":"Crit Care Med"},{"issue":"7","key":"2537_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002338","volume":"14","author":"J Hazeldine","year":"2017","unstructured":"Hazeldine J, Naumann DN, Toman E, Davies D, Bishop JRB, Su Z, Hampson P, Dinsdale RJ, Crombie N, Duggal NA, Harrison P, Belli A, Lord JM (2017) Prehospital immune responses and development of multiple organ dysfunction syndrome following traumatic injury: a prospective cohort study. PLoS Med 14(7):e1002338","journal-title":"PLoS Med"},{"issue":"4","key":"2537_CR40","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s00134-015-4205-3","volume":"42","author":"K Timmermans","year":"2016","unstructured":"Timmermans K, Kox M, Vaneker M, van den Berg M, John A, van Laarhoven A, van der Hoeven H, Scheffer GJ, Pickkers P (2016) Plasma levels of danger-associated molecular patterns are associated with immune suppression in trauma patients. Intensive Care Med 42(4):551\u2013561","journal-title":"Intensive Care Med"},{"issue":"2","key":"2537_CR41","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S0022-510X(00)00501-3","volume":"184","author":"H Reiber","year":"2001","unstructured":"Reiber H, Peter JB (2001) Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs. J Neurol Sci 184(2):101\u2013122","journal-title":"J Neurol Sci"},{"issue":"9","key":"2537_CR42","doi-asserted-by":"publisher","first-page":"496","DOI":"10.52586\/4962","volume":"26","author":"Q Xu","year":"2021","unstructured":"Xu Q, Zhu Y, Wang Q, Han J, Mao F, Zeng S, Chen S, Zhao C, Gu M, Li Z, Luo X, Fu X, Huang Y (2021) Clinical features, treatments, and outcomes of patients with anti-N-methyl-d-aspartate encephalitis\u2014a single-center, retrospective analysis in China. Front Biosci (Landmark Ed) 26(9):496\u2013503","journal-title":"Front Biosci (Landmark Ed)"},{"key":"2537_CR43","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/s41590-018-0064-8","volume":"19","author":"M Huber-Lang","year":"2018","unstructured":"Huber-Lang M, Lambris JD, Ward PA (2018) Innate immune responses to trauma. Nat Immunol 19:327\u2013341","journal-title":"Nat Immunol"},{"issue":"2","key":"2537_CR44","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1523\/JNEUROSCI.2405-14.2015","volume":"35","author":"JM Morganti","year":"2015","unstructured":"Morganti JM, Jopson TD, Liu S, Riparip LK, Guandique CK, Gupta N, Ferguson AR, Rosi S (2015) CCR2 antagonism alters brain macrophage polarization and ameliorates cognitive dysfunction induced by traumatic brain injury. J Neurosci 35(2):748\u2013760","journal-title":"J Neurosci"},{"issue":"Pt 9","key":"2537_CR45","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1093\/brain\/124.9.1734","volume":"124","author":"SL Leib","year":"2001","unstructured":"Leib SL, Clements JM, Lindberg RL, Heimgartner C, Loeffler JM, Pfister LA, T\u00e4uber MG, Leppert D (2001) Inhibition of matrix metalloproteinases and tumour necrosis factor alpha converting enzyme as adjuvant therapy in pneumococcal meningitis. Brain 124(Pt 9):1734\u20131742","journal-title":"Brain"},{"issue":"9","key":"2537_CR46","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1086\/374644","volume":"187","author":"DN Meli","year":"2003","unstructured":"Meli DN, Christen S, Leib SL (2003) Matrix metalloproteinase-9 in pneumococcal meningitis: activation via an oxidative pathway. J Infect Dis 187(9):1411\u20131415","journal-title":"J Infect Dis"},{"issue":"2","key":"2537_CR47","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1136\/jnnp-2011-300411","volume":"83","author":"C Finke","year":"2012","unstructured":"Finke C, Kopp UA, Pruss H, Dalmau J, Wandinger K, Ploner CJ (2012) Cognitive deficits following anti-NMDA receptor encephalitis. J Neurol Neurosurg Psychiatry 83(2):195\u2013198","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Acta Neurologica Belgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-024-02537-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13760-024-02537-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-024-02537-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T11:04:33Z","timestamp":1733223873000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13760-024-02537-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,18]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["2537"],"URL":"https:\/\/doi.org\/10.1007\/s13760-024-02537-6","relation":{},"ISSN":["0300-9009","2240-2993"],"issn-type":[{"value":"0300-9009","type":"print"},{"value":"2240-2993","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,18]]},"assertion":[{"value":"6 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The patients included in the present study provided written informed consent. The study was approved by the ethics committee of Harbin Medical University.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}}]}}